Literature DB >> 11429029

Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.

G W McCaughan1, A Zekry.   

Abstract

The hepatitis C virus (HCV) is recognized as the leading cause for parenterally transmitted hepatitis. It is characterized by a high propensity to chronicity. Several efforts have been directed towards understanding the natural history of chronic HCV infection and the immunopathogenic pathways involved in mediating liver injury in the non-immunosuppressed and immunosuppressed states. In the non-immunosuppressed setting, liver damage seems to be largely immune mediated. In contrast, in the non-immunosuppressed state, there are several other factors that may modify the natural course of the infection and play a role in mediating liver injury. In this review we will address the natural history, virological and immunological aspects of HCV infection. Also, the role played by immunosuppression and organ transplantation in modifying the course of the infection and the pathogenesis of liver injury will be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11429029     DOI: 10.1034/j.1399-3062.2000.020403.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  8 in total

Review 1.  Impact of new treatment options for hepatitis C virus infection in liver transplantation.

Authors:  Elda Righi; Angela Londero; Alessia Carnelutti; Umberto Baccarani; Matteo Bassetti
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 2.  De novo autoimmune hepatitis in liver transplant: State-of-the-art review.

Authors:  Ranka Vukotic; Giovanni Vitale; Antonia D'Errico-Grigioni; Luigi Muratori; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

3.  Update on the Management of Hepatitis C in Liver Transplant Recipients.

Authors:  David A Bobak; Gopal Yadavalli
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

4.  Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.

Authors:  Silvia Della Bella; Andrea Crosignani; Antonio Riva; Pietro Presicce; Alberto Benetti; Renato Longhi; Mauro Podda; Maria L Villa
Journal:  Immunology       Date:  2007-06       Impact factor: 7.397

Review 5.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

Review 6.  Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?

Authors:  Marco Dall'Agata; Annagiulia Gramenzi; Maurizio Biselli; Mauro Bernardi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

7.  Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.

Authors:  J R Peterson; F C Hsu; P A Simkin; M H Wener
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

8.  The hepatic transcriptome in human liver disease.

Authors:  Nicholas A Shackel; Devanshi Seth; Paul S Haber; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Comp Hepatol       Date:  2006-11-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.